Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Weis

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Ugeskrift for Laeger|October 22, 2014
[Increased risk of hepatocellular carcinoma in patients with chronic hepatitis C]Sofie Hallager, Nina Weis
Ugeskrift for Laeger|October 9, 2014
[Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma]Sofie Hallager, Nina Weis
Ugeskrift for Laeger|November 21, 2025
[Vaccination in pregnancy]Ellen Moseholm, Nina Weis
European Journal of Internal Medicine|February 24, 2006
C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?Nina Weis, Thomas Almdal
Ugeskrift for Laeger|October 20, 2012
[The Danish Database for Hepatitis B and C]Nina Weis, Reimar W Thomsen,
Journal of Hepatology|April 25, 2017
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatmentSofie Hallager, Steen Ladelund, Nina Weis
Ugeskrift for Laeger|October 1, 2008
[Salmonella typhi--time to change empiric treatment]Christina Gade, Jørgen Engberg, Nina Weis
Journal of Viral Hepatitis|May 17, 2019
Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes-A systematic reviewAnne Bergløv, Sofie Hallager, Nina Weis
AIDS Care|November 3, 2022
Psychiatric disorders in perinatally HIV-exposed, uninfected children: a systematic reviewSammy Ameri, Ellen Moseholm, Nina Weis
World Journal of Hepatology|June 8, 2017
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic reviewBastian Neesgaard, Morten Ruhwald, Nina Weis
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Ugeskrift for Laeger|October 22, 2014
[Increased risk of hepatocellular carcinoma in patients with chronic hepatitis C]Sofie Hallager, Nina Weis
Ugeskrift for Laeger|October 9, 2014
[Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma]Sofie Hallager, Nina Weis
Ugeskrift for Laeger|November 21, 2025
[Vaccination in pregnancy]Ellen Moseholm, Nina Weis
European Journal of Internal Medicine|February 24, 2006
C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?Nina Weis, Thomas Almdal
Ugeskrift for Laeger|October 20, 2012
[The Danish Database for Hepatitis B and C]Nina Weis, Reimar W Thomsen,
Journal of Hepatology|April 25, 2017
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatmentSofie Hallager, Steen Ladelund, Nina Weis
Ugeskrift for Laeger|October 1, 2008
[Salmonella typhi--time to change empiric treatment]Christina Gade, Jørgen Engberg, Nina Weis
Journal of Viral Hepatitis|May 17, 2019
Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes-A systematic reviewAnne Bergløv, Sofie Hallager, Nina Weis
AIDS Care|November 3, 2022
Psychiatric disorders in perinatally HIV-exposed, uninfected children: a systematic reviewSammy Ameri, Ellen Moseholm, Nina Weis
World Journal of Hepatology|June 8, 2017
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic reviewBastian Neesgaard, Morten Ruhwald, Nina Weis
Pageof 17